Logo

Eurofins C&PC supports pharma-dermato

industry-solutions-clinical-dev

Clinical development

Design and implementation of study protocols tailored to your scientific and regulatory objectives

industry-solutions-md-clinical-trial-management

Clinical project management

Full coordination of trials, from recruitment to close-out, with strict adherence to timelines and budgets

industry-solutions-medical-support

Monitoring and medical oversight

Clinical and medical supervision to ensure participant safety and data integrity  

industry-solutions-md-clinical-trial-management1

Data operations and medical writing

Clinical data management, statistical analyses, and preparation of reports meeting international standards

industry-solutions-cannabis-customized-expert-support

Quality assurance

Audits, SOPs, and compliance with GCP and ISO 14155:2020 standards

Ensuring the safety, efficacy, and regulatory compliance of pharma-dermato products requires deep scientific expertise and a robust clinical infrastructure.

Eurofins C&PC offers comprehensive dermatology-focused services that support the development of products addressing psoriasis, atopic dermatitis, alopecia, rare skin diseases, as well as aesthetic products and medical devices. Our capabilities span strategic and regulatory consulting, early-phase human safety and Proof-of-Concept studies, vasoconstrictor assays for topical corticosteroids, and global Phase II-IV clinical trials for new chemical entities, reformulations with known actives, and generics.

By combining scientific excellence with operational precision, we help you navigate the complexities of dermatological product development and bring safe, effective, and compliant solutions to market.

problemsolution-cosmeceuticals

What sets Eurofins C&PC apart?

Targeted expertise in dermatology and pharma-dermato

Eurofins provides strategic and regulatory consulting for dermatological products, including those addressing psoriasis, atopic dermatitis, alopecia, and rare skin diseases, as well as aesthetic products and medical devices.

Comprehensive clinical capabilities

From early-phase human safety and Proof-of-Concept studies to vasoconstrictor assays and global Phase II-IV trials, our services support the full development lifecycle of new chemical entities, reformulations, and generics.

Integrated, quality-driven approach

With robust clinical project management, medical monitoring, data operations, and quality assurance under GCP and ISO 14155:2020 standards, we ensure your products meet the highest regulatory and scientific expectations.